Share

Investor Information

Johnson & Johnson to Acquire Abiomed

Johnson & Johnson to Acquire Abiomed

Learn More
Johnson & Johnson Hosts Investor Conference Call on Third-Quarter Results

Listen to Webcast: Morgan Stanley 20^th Annual Global Healthcare Conference

Listen to Webcast: 2022 Wells Fargo Securities Healthcare Conference
NYSE: JNJ $177.24 $0.23 (0.130%)
- Day High $178.12
- Day Low $176.86
- Volume 3,058,608
Last Updated: 11/25/2022 01.10 PM

2022 Annual Meeting of Shareholders

2022 Annual Meeting of Shareholders

Annual Meeting Materials and Webcast

2022 ESG Investor Update Webcast

2022 ESG Investor Update Webcast

Learn More

Latest News Releases

Latest News

November 01, 2022

Johnson & Johnson to Acquire Abiomed
Latest News

October 03, 2022

Johnson & Johnson to Participate in the Credit Suisse 31^st Annual Healthcare Conference
Financial

September 14, 2022

Johnson & Johnson Announces $5 Billion Share Repurchase Program

See All News Releases

Webcast: Pharmaceutical Business Review 2021

Webcast: Pharmaceutical Business Review 2021

2021 Health for Humanity Report

2021 Health for Humanity Report

2021 Janssen U.S. Transparency Report

2021 Janssen U.S. Transparency Report

2021 Annual Report

2021 Annual Report

Investor Relations

Quarterly Results

See the latest quarterly sales and earnings from Johnson & Johnson, as well as historical results covering the past ten years.

Learn More
Shareholder Tools
- Email Alerts Subscription
- RSS News Feeds

Investor FAQs

Answers to common questions regarding purchasing and owning Johnson & Johnson stock.

Learn More

ESG Resources

Effective management of ESG matters is a business imperative.

Learn More

Contact Investor Relations

Questions? Please contact Investor Relations: